To understand the challenges that the pharmaceutical industry faces during COVID-19, open-ended interviews were conducted with top pharmaceutical companies around Europe. The methodology followed during the interviews was semi-restrictive, using a general outline of questions that led to other topics based on the spontaneous response of the interviewees, but always about the general topic: COVID-19 and digital transformation. As a result of the interviews, meaningful qualitative data was collected. This paper by Marta Vila Ramos at Pharmalex et al., summarise the main highlights, together with the future vision.